Seems like everybody and their mother is on Ozempic, Rybelsus, or Wygovy these days for weight loss
The bottom line The TL;DR is this: Theres a lot of excitement around GLP-1s and their potential longevity benefits, but its still way too early to say the general population should start taking them for those purposes
GLP-1 analogues have shown significant promise in managing obesity and diabetes, but like any medication, they may have side effects and interact with other drugs
This study provides evidence of their potential risks
Bottom Line Period changes while on GLP-1s are real, and plenty of women experience them
Even as prices come down for GLP-1 weight-loss drugs, much cheaper products marketed as GLP-1 supplements can be alluring to consumers